Search - tctmd.com

Displaying 61 - 80 of 100

Sort: Relevancy | Date

Presentation

Insights from Real-World Femoropopliteal Drug-Coated Balloon (DCB) Treatment: 1-Year Results From IN_PACT Global Clinical Study

Presenter: G.Tepe

February 04, 2015

Presentation

DEBs for Femoropopliteal Lesions Show Better Performance in De Novo Stenosis Than Restenosis

Presenter: Monika Herten

October 16, 2014

Presentation VEINS 2014

Rationale and Novel Treatment Techniques for Treatment of Femoropopliteal Chronic DVT

Presenter: Stephen T. Kee

October 11, 2014

Presentation VEINS 2014

Treatment of Femoropopliteal DVT: Anticoagulation (and Compression) Is Enough

Presenter: Suresh Vedantham

October 10, 2014

Presentation VEINS 2014

DEBATE: Treatment of Femoropopliteal DVT - No, We Must Consider Aggressive Measures

Presenter: Mark J. Garcia

October 10, 2014

Presentation TCT 2014

EXCITE ISR: A Prospective, Randomized Trial of Excimer Laser Atherectomy Versus Balloon Angioplasty for Treatment of Femoropopliteal In-Stent Restenosis

Presenter: Ajay J. Kirtane, Deepak L. Bhatt, Eric J. Dippel

September 16, 2014

Presentation TCT 2014

TCT 532: Economic Outcomes of Endovascular Femoropopliteal Intervention Using Drug-Coated Balloons vs Standard PTA: 1-Year Results from the IN.PACT SFA II Trial

Presenter: Peter A. Schneider, Gunnar Tepe, Michael H. Wholey, Adam Salisbury, MD

September 15, 2014

Presentation TCT 2014

DCB and the Use of Ancillary Devices III: Unmet Technical Needs and Opportunities for Development of Next-Generation Technologies

Presenter: Kenneth Rosenfield, Thomas Zeller, Raghu Kolluri, Arne Schwindt

September 15, 2014

Presentation TCT 2014

DCB and the Use of Ancillary Devices II: Atherectomy - Insights from The DEFINITE AR Trial

Presenter: Kenneth Rosenfield, Thomas Zeller, Raghu Kolluri, Gunnar Tepe

September 15, 2014

Presentation TCT 2014

DCB and the Use of Ancillary Devices I: BMSDCB Interactions Provisional Versus Primary Use?

Presenter: Kenneth Rosenfield, Thomas Zeller, Raghu Kolluri, Francesco Liistro

September 15, 2014

Presentation TCT 2014

DCB Use in the Real World III: The IN.PACT Global Registry: First Report of Prospective Outcomes Using the IN.PACT DCB in an Unrestricted, Real-World Environment

Presenter: Kenneth Rosenfield, Thomas Zeller, Raghu Kolluri, Gary M. Ansel

September 15, 2014

Presentation TCT 2014

DCB Use in the Real World II: DCB for Long and Highly Calcified Vessels

Presenter: Kenneth Rosenfield, Thomas Zeller, Raghu Kolluri, Gunnar Tepe

September 15, 2014

Presentation TCT 2014

DCB Use in the Real World I: In-Stent Restenosis Insights From the FAIR Trial

Presenter: Kenneth Rosenfield, Thomas Zeller, Raghu Kolluri

September 15, 2014

Presentation TCT 2014

Randomized Controlled Trials I: Extended Follow-Up From LEVANT 2 - Analysis of one year Follow-up and Beyond

Presenter: Kenneth Rosenfield, Thomas Zeller, Raghu Kolluri

September 15, 2014

Presentation TCT 2014

Randomized Controlled Trials I: New Insights From INPACT SFA II

Presenter: Kenneth Rosenfield, Thomas Zeller, Raghu Kolluri, John R. Laird Jr

September 15, 2014

Presentation TCT 2014

DCB in De Novo Lesions: Critical Review of FIH Data, Efficacy, and Long-term Durability

Presenter: Kenneth Rosenfield, Thomas Zeller, Raghu Kolluri

September 15, 2014

Presentation TCT 2014

Excimer Laser for Femoropopliteal In-Stent Restenosis: Light at the End of the Tunnel?

Presenter: John R. Laird Jr, Daniel J. McCormick, Dmitriy N. Feldman, Carlos I. Mena-Hurtado

September 13, 2014

Presentation TCT 2014

Bioresorbable Scaffolds: Status Update and Potential Role in Femoropopliteal Disease

Presenter: Robert M. Bersin, Dierk Scheinert, Roger Gammon, Mahmood K. Razavi

September 13, 2014

Presentation TCT 2014

Calcification in Femoropopliteal Intervention: Management Options and Outcomes

Presenter: Robert M. Bersin, Dierk Scheinert, Roger Gammon, D. Christopher Metzger

September 13, 2014

Presentation EuroPCR 2014

Post‐Market Surveillance Study of Paclitaxel‐Eluting Nitinol Stents for Treating FemoropoplitealArtery Disease in Japan: 12‐Month Results

Presenter: Hiroyoshi Yokoi

May 21, 2014

Advertisement

Insights from Real-World Femoropopliteal Drug-Coated Balloon (DCB) Treatment: 1-Year Results From IN_PACT Global Clinical Study

DEBs for Femoropopliteal Lesions Show Better Performance in De Novo Stenosis Than Restenosis

Rationale and Novel Treatment Techniques for Treatment of Femoropopliteal Chronic DVT

Treatment of Femoropopliteal DVT: Anticoagulation (and Compression) Is Enough

DEBATE: Treatment of Femoropopliteal DVT - No, We Must Consider Aggressive Measures

EXCITE ISR: A Prospective, Randomized Trial of Excimer Laser Atherectomy Versus Balloon Angioplasty for Treatment of Femoropopliteal In-Stent Restenosis

TCT 532: Economic Outcomes of Endovascular Femoropopliteal Intervention Using Drug-Coated Balloons vs Standard PTA: 1-Year Results from the IN.PACT SFA II Trial

DCB and the Use of Ancillary Devices III: Unmet Technical Needs and Opportunities for Development of Next-Generation Technologies

DCB and the Use of Ancillary Devices II: Atherectomy - Insights from The DEFINITE AR Trial

DCB and the Use of Ancillary Devices I: BMSDCB Interactions Provisional Versus Primary Use?

DCB Use in the Real World III: The IN.PACT Global Registry: First Report of Prospective Outcomes Using the IN.PACT DCB in an Unrestricted, Real-World Environment

DCB Use in the Real World II: DCB for Long and Highly Calcified Vessels

DCB Use in the Real World I: In-Stent Restenosis Insights From the FAIR Trial

Randomized Controlled Trials I: Extended Follow-Up From LEVANT 2 - Analysis of one year Follow-up and Beyond

Randomized Controlled Trials I: New Insights From INPACT SFA II

DCB in De Novo Lesions: Critical Review of FIH Data, Efficacy, and Long-term Durability

Excimer Laser for Femoropopliteal In-Stent Restenosis: Light at the End of the Tunnel?

Bioresorbable Scaffolds: Status Update and Potential Role in Femoropopliteal Disease

Calcification in Femoropopliteal Intervention: Management Options and Outcomes

Post‐Market Surveillance Study of Paclitaxel‐Eluting Nitinol Stents for Treating FemoropoplitealArtery Disease in Japan: 12‐Month Results

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content